InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
2
T+90 hit rate
100%
T+90 mean return
+24.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by BARKER SAM L, Director. Insider active across 2 companies, notably Cyclacel Pharmaceuticals, Inc.. In total, 13 reports have been recorded. Breakdown: 2 buys · 2 sells. Total volume traded: €9k. History available since 15 June 2021. The latest transaction was disclosed on 3 June 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
89,312 shares0Common StockSEC:0001062822-26-000104:0
36,810 shares0Common StockSEC:0001127602-25-014143:0
8,032 shares0Common StockSEC:0001127602-24-013554:0
21,219 shares0Common StockSEC:0001104659-23-077660:0
9,302 shares0Common StockSEC:0001127602-23-016430:0
15,822 shares0Common StockSEC:0001104659-22-071892:0
4,024 shares0Common StockSEC:0001127602-22-012825:0
12 shares@ US$3.57160.4% of flowCommon StockSEC:0001104659-21-145913:0
12 shares@ US$3.57160.4% of flowCommon StockSEC:0001104659-21-145913
1,000 shares@ US$5.0049.6% of flowCommon StockSEC:0001104659-21-109337:0
Ideal exit: 21 May 2022 (T+270)
1,000 shares@ US$5.0049.6% of flowCommon StockSEC:0001104659-21-109337
Ideal exit: 21 May 2022 (T+270)
2,374 shares0Common StockSEC:0001104659-21-082604
2,374 shares0Common StockSEC:0001104659-21-082604:0
13 of 13 declarations
About BARKER SAM L
Sam L. Barker is a Board Member at Cyclacel Pharmaceuticals, Inc. and Lexicon Pharmaceuticals, Inc. He plays a key role in the governance of the companies, bringing his expertise in the pharmaceutical sector. His involvement on the boards is crucial for strategic development.
